Long-term outcomes with conventional fractionated and stereotactic radiotherapy for suspected heart-base tumours in dogs.
Hansen KS, Théon AP, Willcox JL, Stern JA, Kent MS.
Vet Comp Oncol. 2021 Mar;19(1):191-200. doi: 10.1111/vco.12662. Epub 2020 Nov 12.
PMID:33135852
Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: A systematic review and meta-analysis.
Nguyen T, Duong C, Sheppard JP, Lee SJ, Kishan AU, Lee P, Tenn S, Chin R, Kaprealian TB, Yang I.
[Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].
Blais E, Pichon B, Mampuya A, Antoine M, Lagarde P, Kantor G, Breton-Callu C, Lefebvre C, Gerard M, Aamarcha A, Ozsahin M, Bourhis J, Maingon P, Troussier I, Pourel N.
Cancer Radiother. 2017 Oct;21(6-7):584-596. doi: 10.1016/j.canrad.2017.07.046. Epub 2017 Sep 5.
PMID:28886981
Fractionated stereotactic radiotherapy: rationale and methods.
Solberg TD, Selch MT, Smathers JB, DeSalles AA.
Med Dosim. 1998 Fall;23(3):209-19. doi: 10.1016/s0958-3947(98)00016-8.
PMID:9783274
Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: A systematic review and meta-analysis.
Li X, Li Y, Cao Y, Li P, Liang B, Sun J, Feng E.
J Neurol Sci. 2017 Jan 15;372:110-116. doi: 10.1016/j.jns.2016.11.024. Epub 2016 Nov 15.